<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36996871</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>617</Volume><Issue>7961</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Adeno-associated virus type 2 in US children with acute severe hepatitis.</ArticleTitle><Pagination><StartPage>574</StartPage><EndPage>580</EndPage><MedlinePgn>574-580</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-023-05949-1</ELocationID><Abstract><AbstractText>As of August 2022, clusters of acute severe hepatitis of unknown aetiology in children have been reported from 35 countries, including the USA<sup>1,2</sup>. Previous studies have found human adenoviruses (HAdVs) in the blood from patients in Europe and the USA<sup>3-7</sup>, although it is unclear whether this virus is causative. Here we used PCR testing, viral enrichment-based sequencing and agnostic metagenomic sequencing to analyse samples from 16 HAdV-positive cases from 1 October 2021 to 22 May 2022, in parallel with 113 controls. In blood from 14 cases, adeno-associated virus type 2 (AAV2) sequences were detected in 93% (13 of 14), compared to 4 (3.5%) of 113 controls (P &lt; 0.001) and to 0 of 30 patients with hepatitis of defined aetiology (P &lt; 0.001). In controls, HAdV type 41 was detected in blood from 9 (39.1%) of the 23 patients with acute gastroenteritis (without hepatitis), including 8 of 9 patients with positive stool HAdV testing, but co-infection with AAV2 was observed in only 3 (13.0%) of these 23 patients versus 93% of cases (P &lt; 0.001). Co-infections by Epstein-Barr virus, human herpesvirus 6 and/or enterovirus A71 were also detected in 12 (85.7%) of 14 cases, with higher herpesvirus detection in cases versus controls (P &lt; 0.001). Our findings suggest that the severity of the disease is related to co-infections involving AAV2 and one or more helper viruses.</AbstractText><CopyrightInformation>© 2023. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Servellita</LastName><ForeName>Venice</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sotomayor Gonzalez</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8930-745X</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lamson</LastName><ForeName>Daryl M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Wadsworth Center, New York State Department of Health, David Axelrod Institute, Albany, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foresythe</LastName><ForeName>Abiodun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huh</LastName><ForeName>Hee Jae</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazinet</LastName><ForeName>Adam L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-9152-5923</Identifier><AffiliationInfo><Affiliation>National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergman</LastName><ForeName>Nicholas H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bull</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Federal Bureau of Investigation Laboratory Division/Scientific Response and Analysis Unit, Quantico, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Karla Y</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodrich</LastName><ForeName>Jennifer S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovett</LastName><ForeName>Sean P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>Kisha</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radune</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hatada</LastName><ForeName>April</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>California Department of Public Health, Richmond, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Chao-Yang</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>California Department of Public Health, Richmond, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>Kyle</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>California Department of Public Health, Richmond, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertumen</LastName><ForeName>J Bradford</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>California Department of Public Health, Richmond, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>California Department of Public Health, Richmond, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oluniyi</LastName><ForeName>Paul E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stryke</LastName><ForeName>Doug</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaber</LastName><ForeName>Rayah</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Florida Department of Health, Tallahassee, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leslie</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Illinois Department of Public Health, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyons</LastName><ForeName>Zin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>North Carolina Department of Health and Human Services, Raleigh, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hedman</LastName><ForeName>Hayden D</ForeName><Initials>HD</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>South Dakota Department of Health, Pierre, SD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parashar</LastName><ForeName>Umesh</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Maureen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Association for Public Health Laboratories, Silver Spring, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wroblewski</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Association for Public Health Laboratories, Silver Spring, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oberste</LastName><ForeName>M Steven</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tate</LastName><ForeName>Jacqueline E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Julia M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-7872-316X</Identifier><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugerman</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potts</LastName><ForeName>Caelin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chhabra</LastName><ForeName>Preeti</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Pediatric Hepatitis of Unknown Etiology Working Group</CollectiveName></Author><Author ValidYN="Y"><LastName>Ingram</LastName><ForeName>L Amanda</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Alabama Department of Public Health, Montgomery, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiau</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Britt</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutierrez Sanchez</LastName><ForeName>Luz Helena</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciric</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rostad</LastName><ForeName>Christina A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinjé</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirking</LastName><ForeName>Hannah L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wadford</LastName><ForeName>Debra A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-8630-427X</Identifier><AffiliationInfo><Affiliation>California Department of Public Health, Richmond, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raborn</LastName><ForeName>R Taylor</ForeName><Initials>RT</Initials><Identifier Source="ORCID">0000-0001-6249-8033</Identifier><AffiliationInfo><Affiliation>National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St George</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Wadsworth Center, New York State Department of Health, David Axelrod Institute, Albany, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Science, University at Albany, SUNY, Albany, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Charles Y</ForeName><Initials>CY</Initials><Identifier Source="ORCID">0000-0003-2915-2094</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA. charles.chiu@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, San Francisco, CA, USA. charles.chiu@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chan-Zuckerberg Biohub, San Francisco, CA, USA. charles.chiu@ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R33 HD105618</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R61 HD105618</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001150</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000623888">Adeno-associated virus-2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nature. 2023 May;617(7961):471-472. doi: 10.1038/d41586-023-00570-8</RefSource><PMID Version="1">36997704</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000258" MajorTopicYN="Y">Adenovirus Infections, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000229" MajorTopicYN="Y">Dependovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020031" MajorTopicYN="N">Epstein-Barr Virus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006505" MajorTopicYN="Y">Hepatitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004854" MajorTopicYN="N">Herpesvirus 4, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015654" MajorTopicYN="N">Herpesvirus 6, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006378" MajorTopicYN="N">Helper Viruses</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>C.Y.C. is a founder of Delve Bio and on the scientific advisory board for Delve Bio, Mammoth Biosciences, BiomeSense and Poppy Health. He is also a co-inventor on US patent 11380421, “Pathogen detection using next generation sequencing”, under which algorithms for taxonomic classification, filtering and pathogen detection are used by SURPI+ software. C.Y.C. receives research support unrelated to this manuscript from Abbott Laboratories, Inc. The institution of C.A.R. has received financial support to conduct clinical research unrelated to this manuscript from BioFire Inc., GSK, Janssen, MedImmune, Merck, Moderna, Novavax, PaxVax, Pfizer, Regeneron and Sanofi-Pasteur. She is co-inventor of patented respiratory syncytial virus vaccine technology, which has been licensed to Meissa Vaccines, Inc. K.S.G. receives research support unrelated to this manuscript from Thermo-Fisher and has a royalty-generating collaborative agreement with Zeptometrix. The other authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Almendares</LastName><ForeName>Olivia</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balachandran</LastName><ForeName>Neha</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cates</LastName><ForeName>Jordan E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Freeman</LastName><ForeName>Brandi</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kambhampati</LastName><ForeName>Anita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marine</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vega</LastName><ForeName>Everardo</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wikswo</LastName><ForeName>Mary E</ForeName><Initials>ME</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKeever</LastName><ForeName>Erin R</ForeName><Initials>ER</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kelly</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boom</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sahni</LastName><ForeName>Leila C</ForeName><Initials>LC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Englund</LastName><ForeName>Janet A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klein</LastName><ForeName>Eileen J</ForeName><Initials>EJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Staat</LastName><ForeName>Mary A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marsh</LastName><ForeName>Maeve</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ricketts</LastName><ForeName>Erin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clayton</LastName><ForeName>Joshua L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cano</LastName><ForeName>Natalia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oseguera</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blattner</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36996871</ArticleId><ArticleId IdType="pmc">PMC10170441</ArticleId><ArticleId IdType="doi">10.1038/s41586-023-05949-1</ArticleId><ArticleId IdType="pii">10.1038/s41586-023-05949-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khader S, Foster I, Dagens A, Norton A, Sigfrid L. Severe acute hepatitis of unknown aetiology in children-what is known? BMC Med. 2022;20:280. doi: 10.1186/s12916-022-02471-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02471-5</ArticleId><ArticleId IdType="pmc">PMC9336128</ArticleId><ArticleId IdType="pubmed">35906650</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe acute hepatitis of unknown aetiology in children - multi-country. WHO Disease Outbreak Newshttps://www.who.int/emergencies/disease-outbreak-news/item/2022-DON400 (2022).</Citation></Reference><Reference><Citation>Cates J, et al. Interim analysis of acute hepatitis of unknown etiology in children aged &lt;10 years - United States, October 2021-June 2022. MMWR Morb. Mortal. Wkly Rep. 2022;71:852–858. doi: 10.15585/mmwr.mm7126e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7126e1</ArticleId><ArticleId IdType="pubmed">35771734</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsheikh R, et al. Acute hepatitis of unknown origin in children: Behind the statistics. Hepatology. 2022 doi: 10.1002/hep.32682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.32682</ArticleId><ArticleId IdType="pubmed">35862247</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez Sanchez LH, et al. A case series of children with acute hepatitis and human adenovirus infection. N. Engl. J. Med. 2022 doi: 10.1056/NEJMoa2206294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2206294</ArticleId><ArticleId IdType="pmc">PMC9808750</ArticleId><ArticleId IdType="pubmed">35830653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelgeri C, et al. Clinical spectrum of children with acute hepatitis of unknown cause. N. Engl. J. Med. 2022 doi: 10.1056/NEJMoa2206704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2206704</ArticleId><ArticleId IdType="pubmed">35830627</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh K, et al. Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022. Euro Surveill. 2022;27:2200318. doi: 10.2807/1560-7917.ES.2022.27.15.2200318.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.15.2200318</ArticleId><ArticleId IdType="pmc">PMC9012090</ArticleId><ArticleId IdType="pubmed">35426362</ArticleId></ArticleIdList></Reference><Reference><Citation>Technical Report: Acute Hepatitis of Unknown Cause (CDC, 2022); https://www.cdc.gov/ncird/investigation/hepatitis-unknown-cause/technical-report.html.</Citation></Reference><Reference><Citation>Kager J, et al. Fulminant adenoviral-induced hepatitis in immunosuppressed patients. Viruses. 2022;14:1459. doi: 10.3390/v14071459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14071459</ArticleId><ArticleId IdType="pmc">PMC9323657</ArticleId><ArticleId IdType="pubmed">35891439</ArticleId></ArticleIdList></Reference><Reference><Citation>Hierholzer JC. Adenoviruses in the immunocompromised host. Clin. Microbiol. Rev. 1992;5:262–274. doi: 10.1128/CMR.5.3.262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.5.3.262</ArticleId><ArticleId IdType="pmc">PMC358244</ArticleId><ArticleId IdType="pubmed">1323383</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 2019;18:358–378. doi: 10.1038/s41573-019-0012-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-019-0012-9</ArticleId><ArticleId IdType="pmc">PMC6927556</ArticleId><ArticleId IdType="pubmed">30710128</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier AF, Fraefel C, Seyffert M. The interplay between adeno-associated virus and its helper viruses. Viruses. 2020;12:662. doi: 10.3390/v12060662.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12060662</ArticleId><ArticleId IdType="pmc">PMC7354565</ArticleId><ArticleId IdType="pubmed">32575422</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao G, et al. Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl Acad. Sci. USA. 2003;100:6081–6086. doi: 10.1073/pnas.0937739100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0937739100</ArticleId><ArticleId IdType="pmc">PMC156329</ArticleId><ArticleId IdType="pubmed">12716974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho, A. et al. Adeno-associated virus 2 infection in children with non-A-E hepatitis. Nature10.1038/s41586-023-05948-2 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36996873</ArticleId></ArticleIdList></Reference><Reference><Citation>Recommendations for adenovirus testing and reporting of children with acute hepatitis of unknown etiology. CDC Health Alert Networkhttps://emergency.cdc.gov/han/2022/han00462.asp (2022).</Citation></Reference><Reference><Citation>Chiu CY, Miller SA. Clinical metagenomics. Nat. Rev. Genet. 2019;20:341–355. doi: 10.1038/s41576-019-0113-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-019-0113-7</ArticleId><ArticleId IdType="pmc">PMC6858796</ArticleId><ArticleId IdType="pubmed">30918369</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng X, et al. Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance. Nat. Microbiol. 2020;5:443–454. doi: 10.1038/s41564-019-0637-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0637-9</ArticleId><ArticleId IdType="pmc">PMC7047537</ArticleId><ArticleId IdType="pubmed">31932713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KW, et al. Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing. Sci. Rep. 2021;11:3934. doi: 10.1038/s41598-021-83642-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-83642-x</ArticleId><ArticleId IdType="pmc">PMC7887263</ArticleId><ArticleId IdType="pubmed">33594223</ArticleId></ArticleIdList></Reference><Reference><Citation>Negro F. Hepatitis D virus coinfection and superinfection. Cold Spring Harb. Perspect. Med. 2014;4:a021550. doi: 10.1101/cshperspect.a021550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a021550</ArticleId><ArticleId IdType="pmc">PMC4208707</ArticleId><ArticleId IdType="pubmed">25368018</ArticleId></ArticleIdList></Reference><Reference><Citation>Urban S, Neumann-Haefelin C, Lampertico P. Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease. Gut. 2021;70:1782–1794. doi: 10.1136/gutjnl-2020-323888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323888</ArticleId><ArticleId IdType="pmc">PMC8355886</ArticleId><ArticleId IdType="pubmed">34103404</ArticleId></ArticleIdList></Reference><Reference><Citation>La Bella T, et al. Adeno-associated virus in the liver: natural history and consequences in tumour development. Gut. 2020;69:737–747. doi: 10.1136/gutjnl-2019-318281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2019-318281</ArticleId><ArticleId IdType="pubmed">31375600</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcedo R, et al. Adeno-associated virus antibody profiles in newborns, children, and adolescents. Clin. Vaccine Immunol. 2011;18:1586–1588. doi: 10.1128/CVI.05107-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.05107-11</ArticleId><ArticleId IdType="pmc">PMC3165215</ArticleId><ArticleId IdType="pubmed">21775517</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CL, et al. Molecular characterization of adeno-associated viruses infecting children. J. Virol. 2005;79:14781–14792. doi: 10.1128/JVI.79.23.14781-14792.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.23.14781-14792.2005</ArticleId><ArticleId IdType="pmc">PMC1287571</ArticleId><ArticleId IdType="pubmed">16282478</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu HL, et al. Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties. Nat. Commun. 2020;11:3279. doi: 10.1038/s41467-020-17047-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17047-1</ArticleId><ArticleId IdType="pmc">PMC7327033</ArticleId><ArticleId IdType="pubmed">32606306</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevret L, et al. Human herpesvirus-6 infection: a prospective study evaluating HHV-6 DNA levels in liver from children with acute liver failure. J. Med. Virol. 2008;80:1051–1057. doi: 10.1002/jmv.21143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21143</ArticleId><ArticleId IdType="pubmed">18428148</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellinger JL, et al. Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. Dig. Dis. Sci. 2014;59:1630–1637. doi: 10.1007/s10620-014-3029-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-014-3029-2</ArticleId><ArticleId IdType="pmc">PMC4250929</ArticleId><ArticleId IdType="pubmed">24464209</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B, et al. Epstein-Barr virus and human herpesvirus-6 reactivation in acute COVID-19 patients. Viruses. 2022;14:1872. doi: 10.3390/v14091872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14091872</ArticleId><ArticleId IdType="pmc">PMC9504756</ArticleId><ArticleId IdType="pubmed">36146679</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfopoulou, S. et al. Genomic investigations of unexplained acute hepatitis in children. Nature10.1038/s41586-023-06003-w (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10170458</ArticleId><ArticleId IdType="pubmed">36996872</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller S, et al. Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid. Genome Res. 2019;29:831–842. doi: 10.1101/gr.238170.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.238170.118</ArticleId><ArticleId IdType="pmc">PMC6499319</ArticleId><ArticleId IdType="pubmed">30992304</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 2013;30:772–780. doi: 10.1093/molbev/mst010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/mst010</ArticleId><ArticleId IdType="pmc">PMC3603318</ArticleId><ArticleId IdType="pubmed">23329690</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 2015;32:268–274. doi: 10.1093/molbev/msu300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msu300</ArticleId><ArticleId IdType="pmc">PMC4271533</ArticleId><ArticleId IdType="pubmed">25371430</ArticleId></ArticleIdList></Reference><Reference><Citation>QuickFacts: Alabama. US Census Bureauhttps://www.census.gov/quickfacts/AL (2021).</Citation></Reference><Reference><Citation>Esona MD, et al. Rotavirus genotype trends and gastrointestinal pathogen detection in the United States, 2014-2016: results from the New Vaccine Surveillance Network. J. Infect. Dis. 2021;224:1539–1549. doi: 10.1093/infdis/jiab177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab177</ArticleId><ArticleId IdType="pubmed">33822119</ArticleId></ArticleIdList></Reference><Reference><Citation>Heim A, Ebnet C, Harste G, Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J. Med. Virol. 2003;70:228–239. doi: 10.1002/jmv.10382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10382</ArticleId><ArticleId IdType="pubmed">12696109</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyman WH, et al. Prospective study of etiologic agents of acute gastroenteritis outbreaks in child care centers. J. Pediatr. 2009;154:253–257. doi: 10.1016/j.jpeds.2008.07.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2008.07.057</ArticleId><ArticleId IdType="pubmed">18783794</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X, Erdman DD. Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene. Arch. Virol. 2006;151:1587–1602. doi: 10.1007/s00705-005-0722-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-005-0722-7</ArticleId><ArticleId IdType="pubmed">16502282</ArticleId></ArticleIdList></Reference><Reference><Citation>Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J. Mol. Biol. 1990;215:403–410. doi: 10.1016/S0022-2836(05)80360-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2836(05)80360-2</ArticleId><ArticleId IdType="pubmed">2231712</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada M, Ogawa T, Kubonoya H, Yoshizumi H, Shinozaki K. Detection and sequence-based typing of human adenoviruses using sensitive universal primer sets for the hexon gene. Arch. Virol. 2007;152:1–9. doi: 10.1007/s00705-006-0842-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-006-0842-8</ArticleId><ArticleId IdType="pubmed">16957827</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis M, et al. Molecular detection of viral causes of encephalitis and meningitis in New York State. J. Med. Virol. 2011;83:2172–2181. doi: 10.1002/jmv.22169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.22169</ArticleId><ArticleId IdType="pubmed">22012726</ArticleId></ArticleIdList></Reference><Reference><Citation>Quick J, et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat. Protoc. 2017;12:1261–1276. doi: 10.1038/nprot.2017.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2017.066</ArticleId><ArticleId IdType="pmc">PMC5902022</ArticleId><ArticleId IdType="pubmed">28538739</ArticleId></ArticleIdList></Reference><Reference><Citation>Naccache SN, et al. A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res. 2014;24:1180–1192. doi: 10.1101/gr.171934.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.171934.113</ArticleId><ArticleId IdType="pmc">PMC4079973</ArticleId><ArticleId IdType="pubmed">24899342</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearse M, et al. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics. 2012;28:1647–1649. doi: 10.1093/bioinformatics/bts199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts199</ArticleId><ArticleId IdType="pmc">PMC3371832</ArticleId><ArticleId IdType="pubmed">22543367</ArticleId></ArticleIdList></Reference><Reference><Citation>Bushnell, B. BBMap: a fast, accurate, splice-aware aligner. https://www.osti.gov/servlets/purl/1241166 (2014).</Citation></Reference><Reference><Citation>Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat. Methods. 2012;9:357–359. doi: 10.1038/nmeth.1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1923</ArticleId><ArticleId IdType="pmc">PMC3322381</ArticleId><ArticleId IdType="pubmed">22388286</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubaugh ND, et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 2019;20:8. doi: 10.1186/s13059-018-1618-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-018-1618-7</ArticleId><ArticleId IdType="pmc">PMC6325816</ArticleId><ArticleId IdType="pubmed">30621750</ArticleId></ArticleIdList></Reference><Reference><Citation>Virtanen P, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods. 2020;17:261–272. doi: 10.1038/s41592-019-0686-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0686-2</ArticleId><ArticleId IdType="pmc">PMC7056644</ArticleId><ArticleId IdType="pubmed">32015543</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A Language and Environmental for Statistical Computinghttp://www.R-project.org (R Foundation for Statistical Computing, 2013).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>